Skip to main content

Table 2 Restored or ameliorated phenotypes in Shank3 mouse models displaying the targeted domain(s), the experimental paradigms, and the drug name

From: A multifaceted approach for analyzing complex phenotypic data in rodent models of autism

Domain

Phenoterm

Experimental paradigm

Effect

Agent

Citation

All

Reward reinforced choice behavior

Operant conditioning paradigm

Ameliorated

CDPPB

[49]

Protein localization: synapse

Western blot: striatum

Ameliorated

Synaptic plasticity: striatal LTD

Whole-cell patch clamp

Restored

General locomotor activity

Open field test

Restored

MPEP

Self-grooming: perseveration

Grooming behavior assessments

Ameliorated

ANK

Motor coordination and balance

Accelerating rotarod test

Restored

IGF-1(high dose)

[50]

Neuroreceptor activity

Whole-cell patch clamp

Restored

Synaptic plasticity: hippocampal LTP

Restored

Neuroreceptor activity

Restored

Peptide derivative of IGF-1

Synaptic plasticity: hippocampal LTP

Restored

PRO

Synaptic transmission: excitatory

Whole-cell patch clamp

Ameliorated

Constitutively active Rac1

[51]

Social approach

Three-chamber social approach test

Ameliorated

Cytoskeletal organization

Western blot: actin and F-actin levels

Restored

P-cofilin peptide (high dose)

Self-grooming: perseveration

Grooming behavior assessments

Restored

Synaptic neuroreceptor ratio (NMDAR/AMPAR) dependent transmission

Whole-cell patch clamp

Restored

P-cofilin peptide (high dose)#

Synaptic transmission: excitatory

Restored

Social approach

Three-chamber social approach test

Restored

Protein phosphorylation

Western blot

Restored

TG003, CLK2 inhibitor

[52]

Self-grooming: perseveration

Grooming behavior assessments

Ameliorated

Social approach

Three-chamber social approach test

Restored

  1. #P-cofilin delivered by intravenous injection or stereotaxic injection into the prefrontal cortex, administered to different groups of mice, and tested separately